BY ALBERT RONNING-ANDERSSON
-
Novo Holdings tight-lipped over new biotech firm with Harvard connections
The biotech business is called Refuel Biography, and one founder is presently used at Harvard Medical College concentrating on aging-related illness.
-
After rejection and delay: FDA approves Ascendis’ drug Yorvipath
Ascendis is wrapping up manufacturing of the medicine for the United States market and anticipates the initial products to be readily available in the initial quarter of 2025.
-
Ambu receives European approval for new duodenoscope
After the United States Fda accepted Ambu’s brand-new duodenoscope in April, European authorities are currently doing the same.
